Stay updated on Poziotinib + T-DM1 in HER2+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Poziotinib + T-DM1 in HER2+ Breast Cancer Clinical Trial page.

Latest updates to the Poziotinib + T-DM1 in HER2+ Breast Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedFooter shows Revision: v3.3.2 replacing v3.2.0; no study details, eligibility criteria, or results are altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check33 days agoChange DetectedRemoved the global government-funding notice about possible delays and operating status. There are no changes to the study details, eligibility criteria, or trial outcomes on the page.SummaryDifference0.4%

- Check47 days agoChange DetectedThe two screenshots show only superficial UI changes to the study page; core study information (title, conditions, eligibility, interventions, outcomes) remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check76 days agoChange DetectedCore content updated to reflect a new operating-status notice and a new version (v3.2.0); previous version v3.1.0 removed.SummaryDifference5%

- Check83 days agoChange Detected- Updated revision from v3.0.2 to v3.1.0. This indicates a new version release, but does not imply substantive changes to content.SummaryDifference0.1%

- Check97 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, indicating a new release. The 'Back to Top' element was removed, a minor UI change.SummaryDifference0.3%

Stay in the know with updates to Poziotinib + T-DM1 in HER2+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Poziotinib + T-DM1 in HER2+ Breast Cancer Clinical Trial page.